Latest Strategic Shift News

Page 29 of 91
Opthea Limited reported a 26% reduction in net loss for FY2025 despite discontinuing its wet AMD drug after failed Phase III trials. The company settled its Development Funding Agreement with investors, securing liquidity and planning a strategic pivot.
Ada Torres
Ada Torres
29 Aug 2025
Stakk Limited reports a striking 158% year-over-year revenue increase in FY25, driven by its Embedded Finance solutions and strategic partnerships. The company’s pivot from B2C to B2B signals a focused growth trajectory into FY26.
Claire Turing
Claire Turing
29 Aug 2025
TasFoods reports a $3.6 million net loss for H1 2025, impacted by oversupply and discounted poultry prices, while advancing key initiatives including pet treats expansion and planned divestments.
Eva Park
Eva Park
29 Aug 2025
Delorean Corporation reveals a strategic shift from EPC contractor to owner-operator of bioenergy assets, unveiling a $500 million-plus project portfolio despite a FY25 revenue dip and loss. The company is positioning itself at the forefront of Australia’s renewable gas market.
Victor Sage
Victor Sage
29 Aug 2025
Delorean Corporation reported a strategic shift in FY25, transitioning from third-party bioenergy construction to owning and operating renewable gas infrastructure, resulting in a $4.1 million loss but positioning the company for future multi-revenue growth.
Victor Sage
Victor Sage
29 Aug 2025
BauMart Holdings Limited has dramatically reduced its net loss to just $123,086 in FY25, down from $4.68 million the previous year, amid a strategic pivot and successful capital raise.
Victor Sage
Victor Sage
29 Aug 2025
BauMart Holdings Limited has dramatically reduced its net loss to $123,086 for the year ended June 2025, down from $4.68 million the previous year, as it advances strategic initiatives and strengthens its financial position through a rights issue.
Victor Sage
Victor Sage
29 Aug 2025
Yojee Limited reported a 34% revenue decline to $675k and a 29% reduction in net loss to $6.02 million for FY2025, reflecting a strategic pivot and accelerated development of its MOSAIC freight forwarding platform. The company raised $8.9 million to fund growth and platform commercialization.
Sophie Babbage
Sophie Babbage
29 Aug 2025
Argent BioPharma reported a net loss of A$17.84 million for FY2025, reflecting a strategic pivot towards core drug development and clinical advancement. The company secured key EU approvals and raised significant capital to support its neuro-immune modulatory pipeline.
Ada Torres
Ada Torres
29 Aug 2025
Spenda Limited reported a 106% surge in revenue to $11.1 million for FY25, driven by acquisitions and expanded services, yet posted a substantial $24.3 million net loss largely due to goodwill impairment. The company’s strategic moves and funding needs highlight a pivotal phase ahead.
Victor Sage
Victor Sage
29 Aug 2025
Aumake Limited reported a strong 54% jump in revenue to nearly $40 million for FY25, while cutting its net loss by 45%. The company’s strategic pivot to higher-margin products and key distribution deals set the stage for an ambitious FY26.
Victor Sage
Victor Sage
29 Aug 2025
Elanor Investors Group reported a substantial $157.8 million net loss for FY24 amid asset devaluations and debt covenant breaches, prompting a strategic recapitalisation and leadership transition.
Eva Park
Eva Park
29 Aug 2025